Search for dissertations about: "pharmacometric"
Showing result 11 - 15 of 45 swedish dissertations containing the word pharmacometric.
-
11. Pharmacometric tools to support translational drug development
Abstract : The use of model-informed drug development has been shown to save significant costs and improve decision making early in the drug development process. The work in this PhD thesis aimed to employ pharmacometric tools to support translational drug development from the preclinical to the late clinical stages. READ MORE
-
12. Pharmacometric Methods and Novel Models for Discrete Data
Abstract : Pharmacodynamic processes and disease progression are increasingly characterized with pharmacometric models. However, modelling options for discrete-type responses remain limited, although these response variables are commonly encountered clinical endpoints. Types of data defined as discrete data are generally ordinal, e.g. READ MORE
-
13. Pharmacometric models in the development of biological medicinal products
Abstract : Biological medicinal products (BMPs) are a successful class of drugs that are indicated in numerous diseases. Common among them is that complexities associated with their manufacture and analysis lead to a high cost compared to small-molecular weight drugs. READ MORE
-
14. Pharmacometric models to inform dose selection and study design : Applied in hemophilia and tuberculosis
Abstract : While tuberculosis is a global pandemic, hemophilia is a rare disease which many have not heard of. Due to tuberculosis mainly being a problem in developing countries and hemophilia being a rare disease, they are not as heard of as other diseases such as cancer or metabolic diseases which are on the rise in Western societies. READ MORE
-
15. Pharmacometric Evaluation of Biomarkers to Improve Treatment in Oncology
Abstract : Cancer is a family of many different diseases with substantial heterogeneity also within the same cancer type. In the era of personalized medicine, it is desirable to identify an early response to treatment (i.e., a biomarker) that can predict the long-term outcome with respect to both safety and efficacy. READ MORE